Experimental vaccine for common cancer shows potential in clinical trial
A Memorial Sloan Kettering phase 1 clinical trial revealed an immune response in some pancreatic cancer patients. Study ...
Pancreatic cancer vaccine shows promise, according to study
In trials, a vaccine for pancreatic cancer developed by Sloan-Ketterin and BioNTech showed promise, but researchers say it is ...
Becker's Hospital Review1h
Trial shows promise of mRNA vaccines in treating pancreatic cancer
The phase 1 trial results, published Feb. 19 in Nature, evaluated the personalized mRNA neoantigen vaccine autogene cevumeran in combination with surgery, immunotherapy drug atezolizumab and ...
Cure Today6h
Personalized Cancer Vaccine Demonstrates Responses in Kidney Cancer
Dr. Catherine Wu discussed the unique aspects of clear cell renal cell carcinoma and the challenges of targeting it with a ...
The 19th News on MSN7h
For families with sick kids, the rise of vaccine hesitancy could be life-threatening
Some parents are concerned about the recent confirmation of Robert F. Kennedy Jr., who has a history of anti-vaccine views, ...
Can mRNA vaccines help in the fight against pancreatic cancer?
There is new hope in the fight against pancreatic cancer after early trials showed that personalized mRNA vaccines can target ...
Personal vaccine may reduce risk of pancreatic cancer returning after surgery, small study finds
A personalized mRNA vaccine appeared to reduce the chances of pancreatic cancer returning after surgery, according to a study published in the journal Nature.
Could a personalized vaccine help fight pancreatic cancer?
"GMA" examines a preliminary study where a personalized mRNA vaccine showed promise in reducing the risk of pancreatic cancer ...